ipilimumab,nivolumab,cabozantinib
exelixis,bms
['cosmic 313']
presidential symposium iii.... starting in 3....2.....1..
awaiting cosmic 313 results by #esmo2022 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert